Variants, vaccines and vaccination passports: Challenges and chances for travel medicine in 2021

Schlagenhauf, Patricia; Patel, Dipti; Rodríguez‐Morales, Alfonso J.; Gautret, Philippe; Grobusch, Martin P.; Leder, Karin

doi:10.1016/j.tmaid.2021.101996

Cited by 67 publications

(58 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Vaccine passports need to be internationally standardised and must have verifiable credentials that safeguard against problems such as forgery and loss of privacy. WHO does not currently endorse covid-19 vaccine or immunity passports because of these concerns 9. It has, however, initiated a Smart Vaccination Certificate Working Group to establish key specifications and standards for effective and interoperable digital solutions for covid-19 vaccination.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Covid-19 vaccine passports: access, equity, and ethics

Osama

Razai

Majeed

2021

BMJ

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

“…WHO does not currently endorse covid-19 vaccine or immunity passports because of these concerns. 9 It has, however, initiated a Smart Vaccination Certificate Working Group to establish key specifications and standards for effective and interoperable digital solutions for covid-19 vaccination.…”

mentioning

confidence: 99%

Covid-19 vaccine passports: access, equity, and ethics

Osama

Razai

Majeed

2021

BMJ

View full text Add to dashboard Cite

show abstract

“…The main symptoms of infection with the delta variant are sore throat, headaches, and runny nose. The WHO warns that the Delta variant is quickly becoming the main strain of SARS-CoV-2 worldwide, due to its higher transmissibility and mortality rate [7][8][9] . Globally, numerous treatment options have been examined for hospitalized patients with COVID-19 (e.g., antiviral agents [10][11][12] , antimalarial drugs 13 , glucocorticoids 10,14 , convalescent plasma 15,16 , and immunomodulators 10,17−20 .…”

Section: Introductionmentioning

confidence: 99%

Clinical features and laboratory findings first case of B. 1.617.2 (delta) variant concern (VOC) in Iraq

Essa

Ahmed

Bapir

et al. 2021

Preprint

View full text Add to dashboard Cite

Introduction and importance: Since the initial report of severe acute respiratory syndrome (SARS CoV-2) in Wuhan, China in 2019, the virus has constantly mutated, resulting in the appearance of novel variants. In December 2020, the B.1.617.2 (delta) variant concern (VOC) was first reported in India, and rapidly spread around the globe, is now the main brand in the United Kingdom, and it has grown dramatically. The transmission rate of the B.1.617.2 (delta) variant concern is higher origin strain. Case Presentation: Here we present the clinical features and laboratory findings of the first case of B. 1.617.2 (delta) variant concern (VOC) in Iraq. A 6-year-old female child presented with severe abdominal pain, headache, severe vomiting and diarrhea, runny nose, alerted mental status, loss of appetite and fever. The patient was diagnosed with COVID-19 delta variant B.1.617.2 by RT-PCR. The patient was treated by administration glucose saline 4% for 3 days, ceftriaxone vial 1 mg every 12 h for 6 days, and an acetaminophen bottle on need to prevent fever followed by a flagyl bottle every 24 h for 3 days. Conclusion Vaccination and prevention the spread of the virus and against it are important preventive approaches for delta variant. Sore throat, runny nose, headache, and vomiting, diarrhea are the major clinical features of delta variant. Followed by an elevation of the leukocyte WBC, and blood platelets. To reduce the impact of new delta variant B.1.617.2 infection; hand washing, wearing a double mask, avoiding crowded and closed settings, social distancing, lockdown, and ensuring good ventilation are major significant options against this variant.

show abstract

“…Suboptimal vaccination rates have also been reported among HCWs at Hajj [ 19 , 20 ]. These findings forecast a serious problem that could arise following the implementation of “vaccination passports” to allow passengers to avoid official border restrictions and quarantine as part of the global COVID-19 control strategy [ 21 ]. Non-vaccination and use of false vaccination certificates to cross international borders would jeopardise global efforts to curb the pandemic.…”

mentioning

confidence: 99%